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USING COLLAGEN BINDING POLY(N-ISOPROPYLACRYLAMIDE) NANOPARTICLES 
TO PREVENT INTRAVASCULAR PLATELET ADHESION AND ACTIVATION 	  
Abstract 
Balloon angioplasty, the most prevalent non-surgical treatment for Atherosclerosis, damages the 
endothelial layer of the artery, baring an underlying collagenous layer, which causes platelet 
adhesion and activation and eventual thrombosis and intimal hyperplasia.  Previous work in our 
lab has used a collagen-binding peptidoglycan, dermatan-sulfate-SILY (DS-SILY), that has been 
shown to bind to type I collagen and prevent platelet adhesion and activation.  Our goal is to 
fabricate nanoparticle-SILY by cross-linking SILY to a poly(N-isopropylacrylamide) (NIPAm) 
nanoparticle instead of a DS backbone, while retaining the SILY’s high collagen binding affinity 
and platelet inhibition capacity observed in DS-SILY. Using a biotin-streptavidin assay, we 
showed that nanoparticle-SILY has a high binding affinity when applied to a collagen-coated 
surface, starting at a concentration of 1 mg/mL and maximized at concentrations at or above 4 
mg/mL.  Using dynamic light scattering, we showed that the nanoparticle-SILY maintains the 
thermodynamic properties characteristic of NIPAm.  The ability of the particles to inhibit platelet 
binding and activation will be tested by using an ELISA to measure NAP-2 and PF-4 expression 
in platelet rich plasma applied to a collagen surface treated with nanoparticle-SILY. We expect 
to find that nanoparticle-SILY is able to inhibit platelet activation, as evidenced by lower levels 
of NAP-2 and PF-4 released. If it can be shown that nanoparticle-SILY has the capability to 
prevent platelet adhesion and activation, future work could explore the potential of the 
nanoparticles to be loaded with anti-inflammatory peptides and used for the dual purpose of 
targeted drug delivery and collagen shielding.  
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